Literature DB >> 1176891

Continuous replication of Friend virus complex (spleen focus-forming virus-lymphatic leukemia-inducing virus) in mouse embryo fibroblasts. Retention of leukemogenicity and loss of immunosuppressive properties.

R J Eckner.   

Abstract

Exposure of NIH Swiss mouse embryo fibroblasts (MEF) to infectious Friend virus (FV) complex [containing defective spleen focus-forming virus (SFFV) and endogenous NB-tropic leukemia-inducing helper virus (LLV-F)] resulted in the productive infection of these cells by both SFFV and LLV-F. Stocks of SFFV derived after extensive growth in this Swiss MEF cell culture system are fully leukemogenic in adult mice for the induction of erythroleukemia and spleen foci. In addition, in vitro-derived LLV-F, when isolated free of SFFV, is fully leukemogenic for the induction of lymphatic leukemia when inoculated into susceptible newborn BALB/c mice. The host range of in vitro-derived FV complex (i.e., FV-TC) for focus formation in vivo is NB-tropic. Unlike in vivo-derived FV complex, FV-TC does not suppress the responsiveness of murine thymocytes to concanavalin A (Con A) in vitro. Rather, FV-TC acts as a mitogen to nonspecifically stimulate the proliferation of BALB/c thymocytes. The mitogenicity of in vitro-derived FV complex is directly associated with the presence of type-C virus particles, is a heat-labile and UV-sensitive property of the virus, and may be primarily due to LLV since equivalent amounts of LLV with or without SFFV present are equally mitogenic. One in vivo passage of FV-TC resulted in the total loss of this mitogenic property with the reappearance of full immunosuppressive properties. This result demonstrates a clear association between in vivo growth of FV and its ability to suppress mouse thymocytes, and suggests that FV complex (SFFV-LLV) is not inherently immunosuppressive for these cells. While the mechanism of this interconversion between immunostimulatory and fully suppressive virus is unknown, both virus markers appear to be dependent upon the presence of infectious FV.

Entities:  

Mesh:

Year:  1975        PMID: 1176891      PMCID: PMC2189940          DOI: 10.1084/jem.142.4.936

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  Inhibition of phytohemagglutinin- and alloantigen-induced lymphocyte stimulation by Rauscher leukemia virus.

Authors:  P Häyry; D Rago; V Defendi
Journal:  J Natl Cancer Inst       Date:  1970-06       Impact factor: 13.506

2.  ASSAY FOR FRIEND LEUKEMIA VIRUS: RAPID QUANTITATIVE METHOD BASED ON ENUMERATION OF MACROSCOPIC SPLEEN FOCI IN MICE.

Authors:  A A AXELRAD; R A STEEVES
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

3.  Defectivity of Rauscher murine erythroblastosis virus.

Authors:  P Bentvelzen; A M Aarssen; J Brinkhof
Journal:  Nat New Biol       Date:  1972-09-27

4.  Helper-dependent properties of Friend spleen focus-forming virus: effect of the Fv-1 gene on the late stages in virus synthesis.

Authors:  R J Eckner
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

5.  An association between globin messenger RNA and 60S RNA derived from Friend leukemia virus.

Authors:  Y Ikawa; J Ross; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

6.  Defective Friend spleen focus-forming virus: pseudotype neutralization by helper-specific antisera.

Authors:  B J Eckner; R A Steeves
Journal:  Nat New Biol       Date:  1971-02-24

7.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

8.  Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro.

Authors:  M S Hirsch; S M Phillips; C Solnik; P H Black; R S Schwartz; C B Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

9.  Immunization against Gross malignant lymphoma with mouse cell lines chronically infected with non-oncogenic murine C-type viruses.

Authors:  J K Youn; M G Blanchard; G Barski
Journal:  Eur J Cancer       Date:  1974-08       Impact factor: 9.162

10.  Tumor induction by immunologically activated murine leukemia virus.

Authors:  M Y Armstrong; N H Ruddle; M B Lipman; F F Richards
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

View more
  9 in total

1.  Defective Friend spleen focus-forming virus: interfering properties and isolation free from standard leukemia-inducing helper virus.

Authors:  R J Eckner; K L Hettrick
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

2.  Natural killer cell suppression of Friend virus-induced preleukemic hemopoietic stem cells.

Authors:  R J Eckner; M Bennett; K L Hettrick; C Seidler
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

3.  Spontaneous regression of Friend virus-induced erythroleukemia. I. The role of the helper murine leukemia virus component.

Authors:  M Dietz; S P Fouchey; C Longley; M A Rich; P Furmanski
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

4.  Persistence of infectious Friend virus in spleens of mice after spontaneous recovery from virus-induced erythroleukemia.

Authors:  B Chesebro; M Bloom; K Wehrly; J Nishio
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

5.  Spontaneous regression of Friend virus-induced erythroleukemia. VI. Structural and antigenic differences between the regressing and conventional strains of virus.

Authors:  P Furmanski; C Longley; C S Bolles; D L Hines; M Dietz
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

6.  Inducibility of spleen focus-forming virus by BrdUrd is controlled by the differentiated state of the cell.

Authors:  I Greiser-Wilke; W Ostertag; P Goldfarb; A Lang; M Furusawa; J F Conscience
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

7.  Helper-independent mink cell focus-inducing strains of Friend murine type-C virus: potential relationship to the origin of replication-defective spleen focus-forming virus.

Authors:  D H Troxler; E Yuan; D Linemeyer; S Ruscetti; E M Scolnick
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

8.  Cellular regulation in Friend virus induced erythroleukemia. Studies with anemic mice of genotype Sl/Sld.

Authors:  D McCool; T W Mak; A Bernstein
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

9.  Persistence and pathogenicity of defective Friend spleen focus-forming virus. Decreased transplantability of hemopoietic cells as a marker for preleukemic change.

Authors:  R J Eckner; K L Hettrick
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.